Kerala State Drugs and Pharmaceuticals Ltd: drug alert entries
Batches made by Kerala State Drugs and Pharmaceuticals Ltd (as named by CDSCO) that appear in CDSCO drug alerts: 12 entries. For spurious entries, the named company may be the brand owner rather than the actual maker.
Diclofenac Sodium Tablets IP 50 mgNSQ
Result: Sample does not conform to IP standards with respect to the test Dissolution and also shows category B defect of tablets (Capping) as described under DCC Guidelines on NSQ Drugs
Telmisartan Tablets IP 40 mgNSQ
Result: The sample does not conform to IP standards with respect to Description.
Telmisartan Tablets IP 40 mgNSQ
Result: The sample does not conform to IP standards with respect to Description.
Telmisartan Tablets IP 40 mgNSQ
Result: It fails the Descriptive part for tablets as per IP, as specified in the laboratory protocol. As per IP, tablets should have sufficient hardness to withstand handling without crumbling or breaking. These tablets are soft and in powdered condition and cannot be removed from the strips in intact form
Diclofenac Sodium Tabelts IP 50 mgNSQ
Result: The sample does not conform to IP standards. If fails the Descriptive part as per IP,as specified in the Laboratory Protocol.
Diclofenac Sodium Tablets IP 50mgNSQ
Result: Dissolution.
Telmisartan Tablets IP 40 mgNSQ
Result: Description
Telmisartan Tablets IP 40 mgNSQ
Result: Description
Folic Acid Tablets IP 5mgNSQ
Result: Sample fails the test Dissolution as per IP
Diclofenac Sodium Tablets IP 50mgNSQ
Result: Dissolution as per IP
Doxycycline Hyclate Tablets USP-100MGNSQ
Result: Sample fails the test Dissolution as per USP as specified in the Laboratory Protocol
Glimepiride Tablets IP 2mgNSQ
Result: It fails the test "Dissolution". as per IP.